Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA)
Sign Up to like & getrecommendations! Published in 2019 at "Regenerative Therapy"
DOI: 10.1016/j.reth.2018.12.001
Abstract: Introduction Lymphatic anomalies (LAs) refer to a group of diseases involving systemic dysplasia of lymphatic vessels. These lesions are classified as cystic lymphatic malformation (macrocystic, microcystic or mixed), generalized lymphatic anomaly, and Gorham–Stout disease. LAs… read more here.
Keywords: multicenter; treatment; treatment intractable; efficacy ... See more keywords
PALLIATIVE TREATMENT OF INTRACTABLE CANCER PAIN
Sign Up to like & getrecommendations! Published in 2022 at "Acta Clinica Croatica"
DOI: 10.20471/acc.2022.61.s2.14
Abstract: In 10% to 30% cancer-pain cases standard analgesic therapy fails to provide effective pain relief. Interventional techniques, such as peripheral nerve blocks, neuraxial analgesia along with neurolytic blocks may be used for such refractory pain.… read more here.
Keywords: cancer pain; palliative treatment; nerve; pain ... See more keywords
Current Pharmacologic Strategies for Treatment of Intractable Epilepsy in Children
Sign Up to like & getrecommendations! Published in 2021 at "International Neurourology Journal"
DOI: 10.5213/inj.2142166.083
Abstract: Epileptic encephalopathy (EE) is a devastating pediatric disease that features medically resistant seizures, which can contribute to global developmental delays. Despite technological advancements in genetics, the neurobiological mechanisms of EEs are not fully understood, leaving… read more here.
Keywords: intractable epilepsy; treatment intractable; current pharmacologic; strategies treatment ... See more keywords